|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/27/24 Mannkind Corp. 10-K 12/31/23 123:18M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 3.75M
2: EX-4.3 Instrument Defining the Rights of Security Holders HTML 46K
5: EX-10.29 Material Contract HTML 525K
3: EX-10.4 Material Contract HTML 45K
4: EX-10.6 Material Contract HTML 48K
6: EX-23.1 Consent of Expert or Counsel HTML 34K
11: EX-97 Clawback Policy re: Recovery of Erroneously HTML 55K
Awarded Compensation
7: EX-31.1 Certification -- §302 - SOA'02 HTML 39K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 39K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 37K
10: EX-32.2 Certification -- §906 - SOA'02 HTML 37K
13: R1 Document and Entity Information HTML 107K
14: R2 Consolidated Statements of Operations HTML 136K
15: R3 Consolidated Balance Sheets HTML 154K
16: R4 Consolidated Balance Sheets (Parenthetical) HTML 55K
17: R5 Consolidated Statements of Comprehensive Loss HTML 47K
18: R6 Consolidated Statements of Stockholders' Deficit HTML 134K
19: R7 Consolidated Statements of Cash Flows HTML 200K
20: R8 Description of Business HTML 44K
21: R9 Summary of Significant Accounting Policies HTML 155K
22: R10 Acquisition HTML 71K
23: R11 Investments HTML 123K
24: R12 Accounts Receivable HTML 77K
25: R13 Inventories HTML 51K
26: R14 Property and Equipment HTML 79K
27: R15 Goodwill and Other Intangible Asset HTML 58K
28: R16 Accrued Expenses and Other Current Liabilities HTML 80K
29: R17 Borrowings HTML 138K
30: R18 Collaboration, Licensing and Other Arrangements HTML 149K
31: R19 Fair Value of Financial Instruments HTML 108K
32: R20 Common and Preferred Stock HTML 60K
33: R21 Earnings Per Common Share ("Eps") HTML 82K
34: R22 Stock Award Plans HTML 151K
35: R23 Commitments and Contingencies HTML 199K
36: R24 Employee Benefit Plans HTML 43K
37: R25 Income Taxes HTML 229K
38: R26 Summary of Significant Accounting Policies HTML 232K
(Policies)
39: R27 Summary of Significant Accounting Policies HTML 76K
(Tables)
40: R28 Acquisition (Tables) HTML 66K
41: R29 Investments (Tables) HTML 118K
42: R30 Accounts Receivable (Tables) HTML 73K
43: R31 Inventories (Tables) HTML 49K
44: R32 Property and Equipment (Tables) HTML 72K
45: R33 Goodwill and Other Intangible Asset (Tables) HTML 54K
46: R34 Accrued Expenses and Other Current Liabilities HTML 81K
(Tables)
47: R35 Borrowings (Tables) HTML 95K
48: R36 Collaboration, Licensing and Other Arrangements HTML 132K
(Tables)
49: R37 Fair Value of Financial Instruments (Tables) HTML 101K
50: R38 Earnings Per Common Share ("Eps") (Tables) HTML 82K
51: R39 Stock Award Plans (Tables) HTML 127K
52: R40 Commitments and Contingencies (Tables) HTML 163K
53: R41 Income Taxes (Tables) HTML 221K
54: R42 Description of Business - Additional Information HTML 41K
(Detail)
55: R43 Summary of Significant Accounting Policies - HTML 97K
Additional Information (Detail)
56: R44 Summary of Significant Accounting Policies - HTML 39K
Additional Information (Detail 1)
57: R45 Summary of Significant Accounting Policies - HTML 51K
Summary of Revenue and Cost of Revenue and Goods
Sold Generated From Product Sales, Services and
Royalties (Detail)
58: R46 Acquisition - Additional Information (Detail) HTML 75K
59: R47 Acquisition - Schedule of Purchase Consideration HTML 45K
(Detail)
60: R48 Acquisition - Schedule of Preliminary Amounts of HTML 65K
Identifiable Assets Acquired and Liabilities
Assumed (Details)
61: R49 Investments - Additional Information (Detail) HTML 86K
62: R50 Investments - Schedule of Contractual Maturities HTML 54K
of Held to Maturity Investments (Detail)
63: R51 Investments - Schedule of Contractual Maturities HTML 45K
of Held to Maturity Investments (Parenthetical)
(Detail)
64: R52 Investments - Schedule of Fair Value of Cash HTML 82K
Equivalents, Long and Short Term Investments
(Detail)
65: R53 Schedule of Accounts Receivable, Net (Detail) HTML 50K
66: R54 Accounts Receivable - Additional Information HTML 56K
(Detail)
67: R55 Schedule of Activities and Ending Reserve Balance HTML 41K
(Detail)
68: R56 Inventories - Components of Inventory (Detail) HTML 44K
69: R57 Inventories - Additional Information (Detail) HTML 41K
70: R58 Property and Equipment, Net (Detail) HTML 71K
71: R59 Property and Equipment - Additional Information HTML 52K
(Detail)
72: R60 Goodwill and Other Intangible Asset - Additional HTML 57K
Information (Detail)
73: R61 Goodwill and Other Intangible Asset - Summary of HTML 45K
Other Intangible Asset (Detail)
74: R62 Accrued Expenses and Other Current Liabilities HTML 57K
(Detail)
75: R63 Accrued Expenses and Other Current Liabilities - HTML 43K
Schedule of Provision for Discounts and Allowances
for Commercial Product Sales (Detail)
76: R64 Borrowings - Summary of Carrying Amount of HTML 57K
Borrowings (Detail)
77: R65 Borrowings - Schedule of Line of Credit Facility HTML 71K
Debt and Key Terms (Detail)
78: R66 Borrowings - Schedule of Line of Credit Facility HTML 54K
Debt and Key Terms (Parenthetical) (Detail)
79: R67 Borrowings - Schedule of Maturities of the HTML 54K
Company's Borrowings (Detail)
80: R68 Borrowings - Senior Convertible Notes - Additional HTML 101K
Information (Detail)
81: R69 Borrowings - MidCap Credit Facility - Additional HTML 127K
Information (Detail)
82: R70 Borrowings - Mann Group Promissory Notes - HTML 106K
Additional Information (Detail)
83: R71 Borrowings - Schedule of Amortization of Premium HTML 39K
and Accretion of Debt Issuance Costs (Detail)
84: R72 Collaboration, Licensing and Other Arrangements - HTML 65K
Schedule of Revenue from Collaborations and
Services (Detail)
85: R73 Collaboration, Licensing and Other Arrangements - HTML 41K
Schedule of Deferred Revenue Related to Revenue
Recognized for Collaborations and Services
(Detail)
86: R74 Collaboration, Licensing and Other Arrangements - HTML 50K
Summary of UT Revenue (Detail)
87: R75 Collaboration, Licensing and Other Arrangements - HTML 122K
Additional Information (Detail)
88: R76 Collaboration, Licensing and Other Arrangements - HTML 49K
Revenue Allocation (Detail)
89: R77 Collaboration, Licensing and Other Arrangements - HTML 60K
Schedule of Revised Anticipated Cash Flows from
Transactions Allocated Performance Obligations
(Detail)
90: R78 Collaboration, Licensing and Other Arrangements - HTML 51K
Schedule of Revised Anticipated Cash Flows from
Transactions Allocated Performance Obligations
(Parenthetical) (Detail)
91: R79 Collaboration, Licensing and Other Arrangements - HTML 43K
Additional Information (Detail 1)
92: R80 Fair Value of Financial Instruments - Fair Value HTML 59K
of Financial Instruments (Detail)
93: R81 Fair Value of Financial Instruments - Fair Value HTML 79K
of Financial Instruments (Parenthetical) (Detail)
94: R82 Common and Preferred Stock - Additional HTML 118K
Information (Detail)
95: R83 Earnings Per Common Share ("EPS") - Components of HTML 62K
Basic and Diluted EPS Computations (Detail)
96: R84 Earnings Per Common Share ("EPS") - Potential HTML 51K
Dilutive Securities Outstanding that are
Considered Antidilutive (Detail)
97: R85 Earnings Per Common Share ("EPS") - Potential HTML 38K
Dilutive Securities Outstanding that are
Considered Antidilutive (Parenthetical) (Detail)
98: R86 Stock Award Plans - Additional Information HTML 170K
(Detail)
99: R87 Stock Award Plans - Stock Based Award Plans HTML 56K
(Detail)
100: R88 Stock Award Plans - Stock Based Compensation HTML 57K
Expense Recognized in Consolidated Statements of
Operations by Category (Detail)
101: R89 Stock Award Plans - Summary of Stock Options HTML 76K
Outstanding (Detail)
102: R90 Stock Award Plans - Summary of Restricted Stock HTML 58K
Unit Activity (Detail)
103: R91 Commitments and Contingencies - Additional HTML 205K
Information (Detail)
104: R92 Commitments and Contingencies - Schedule of HTML 39K
Financing Liability Lease Term and Discount Rate
(Detail)
105: R93 Commitments and Contingencies - Summary of HTML 36K
Financing Liability Costs (Detail)
106: R94 Commitments and Contingencies - Schedule of HTML 52K
Financing Liability Payments (Detail)
107: R95 Commitments and Contingencies - Remaining Purchase HTML 78K
Commitments and Estimated Capacity Fee Liability
Requirements (Detail)
108: R96 Commitments and Contingencies - Remaining Purchase HTML 36K
Commitments and Estimated Capacity Fee Liability
Requirements (Parenthetical) (Detail)
109: R97 Commitments and Contingencies - Schedule of Lease HTML 55K
Term and Discount Rate (Detail)
110: R98 Commitments and Contingencies - Summary of Lease HTML 42K
Information (Detail)
111: R99 Commitments and Contingencies - Schedule of Future HTML 54K
Minimum Office And Vehicle Lease Payments (Detail)
112: R100 Employee Benefit Plans - Additional Information HTML 51K
(Detail)
113: R101 Loss from Continuing Operations Before Provision HTML 42K
for Income Taxes (Detail)
114: R102 Provision for Income Taxes (Detail) HTML 59K
115: R103 Components of Net Deferred Tax Assets (Detail) HTML 78K
116: R104 Effective Tax Rate (Detail) HTML 56K
117: R105 Income Taxes - Additional Information (Detail) HTML 68K
118: R106 Income Taxes - Summary of Positions for which HTML 39K
Significant Change in Unrecognized Tax Benefits
(Detail)
120: XML IDEA XML File -- Filing Summary XML 235K
123: XML XBRL Instance -- mnkd-20231231_htm XML 4.15M
119: EXCEL IDEA Workbook of Financial Report Info XLSX 281K
12: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 7.29M
Linkbases Document -- mnkd-20231231
121: JSON XBRL Instance as JSON Data -- MetaLinks 791± 1.31M
122: ZIP XBRL Zipped Folder -- 0000950170-24-021423-xbrl Zip 884K
| EX-31.2 |
Exhibit 31.2
RULE 13a-14(a)/15d-14(a) CERTIFICATION
I, Steven B. Binder, certify that:
1. I have reviewed this Annual Report on Form 10-K of MannKind Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ Steven B. Binder |
Chief Financial Officer |
Date: February 27, 2024
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/27/24 | 8-K | ||
| For Period end: | 12/31/23 | 4 | ||
| List all Filings | ||||